Ryman Healthcare Limited (NZE:RYM)

Market Cap	1.90B -36.6%
Revenue (ttm)	854.47M +12.6%
Net Income	-171.35M
EPS	-0.17
Shares Out	1.01B
PE Ratio	n/a
Forward PE	16.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	662,256
Open	1.850
Previous Close	1.840
Day's Range	1.845 - 1.890
52-Week Range	1.660 - 3.050
Beta	0.33
Analysts	Buy
Price Target	2.80 (+49.89%)
Earnings Date	Nov 25, 2026

About Ryman Healthcare

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the older people in New Zealand and Australia. The company’s villages provide apartments and townhouses, and assisted-living in serviced apartments, and care center, which offers rest homes, hospitals, specialist dementia care, and respite care services. Ryman Healthcare Limited was founded in 1984 and is based in Christchurch, New Zealand.

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1984
• Employees: 7,700
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: RYM

Financial Performance

In fiscal year 2026, Ryman Healthcare's revenue was 854.47 million, an increase of 12.55% compared to the previous year's 759.16 million. Losses were -171.35 million, -66.65% less than in 2025.

Analyst Summary

According to 4 analysts, the average rating for RYM stock is "Buy." The 12-month stock price target is $2.80, which is an increase of 49.89% from the latest price.

Price Target

$2.80

(49.89% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error